scmp.com on MSN1 天
Hong Kong could be first to get Swiss start-up’s drug for diabetic eye disease
OCS-01, an eye drop developed by Oculis Holding and currently under phase 3 trials for diabetic macular edema (DME), can be ...
Novo Nordisk invests $1.2 bln in new rare disease drugs plant in Denmark
Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...
Daily1 天
Intas Pharmaceutical gets CDSCO Panel nod to study Aflibercept Solution for Injection 40 mg ...
Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular ...
Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark
By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...
Can Cipla make inhaled insulin a successful option for diabetes patients?
Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...
Sol-Millennium® Celebrates Positive Feedback on Needle-Free Insulin Injection Device in Canada
Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...
Medscape7 天
A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
Organically Human on MSN3 天
The Most Common Mistakes People With Diabetes Make
Recognizing and addressing these common missteps can pave the way for better diabetes management and overall well-being. ...
West Virginians say medications have helped them lose weight, but coverage can be a problem
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...
New study finds first US obesity decline in 10 years. Is Ozempic a leading factor?
Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023.
The Register-Herald1 天
West Virginians say medications have helped them lose weight, but coverage can be a problem ...
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that’s also being used for weight-loss, he’s down 65 ...